Pharmacokinetics and pharmacodynamics of testosterone pellets in man

The Journal of Clinical Endocrinology and Metabolism
D J HandelsmanL M Boylan

Abstract

We studied the pharmacokinetics and pharmacodynamics of sc implanted pellets of fused crystalline testosterone. Three different regimens (6 x 100 mg, 6 x 200 mg; and 3 x 200 mg) were compared in a prospective, cross-over clinical trial in which androgen deficient men were administered the three-dose combinations in a randomized starting order at intervals of at least 6 months. Plasma free and total testosterone, sex hormone-binding globulin, LH, and FSH were measured before and at monthly intervals for at least 6 months after 111 pellet implantation in 43 men with hypergonadotropic (n = 22) or hypogonadotropic (n = 21) hypogonadism. Total and free testosterone levels peaked at the first month and were maintained at physiological levels for 4 to 5 (600 mg doses) or 6 (1200 mg dose) months after a single implantation. Absorption of testosterone from 100 mg and 200 mg pellets closely approximated zero-order throughout the effective life of the pellets and exhibited a half-duration of 2.5 months. The estimated rate of release of testosterone was 1.5 (95% confidence limits 1.3-1.6) mg/day.200 mg pellet as determined from direct measurement of residue in pellets recovered after extrusion and confirmed independently from percent absor...Continue Reading

Citations

Jan 1, 1996·International Urology and Nephrology·M I Anjum, J H Palmer
Dec 28, 2006·Veterinary Research Communications·P C Mills
Feb 10, 2009·Advances in Therapy·U Srinivas-Shankar, D Sharma
Nov 1, 1995·Contraception·S KimF Anderson
Jun 1, 1992·Pharmacology, Biochemistry, and Behavior·S KolonenM M Airaksinen
May 1, 1994·Pharmacology, Biochemistry, and Behavior·C E LauJ L Falk
Dec 1, 1995·Mutation Research·S H Yim, S S Hee
Jul 1, 1994·Neurobiology of Aging·F E Kaiser, J E Morley
Jul 1, 1993·Neurotoxicology and Teratology·E D LevinJ E Rose
Mar 31, 2004·Biological Psychiatry·Leslie K JacobsenJohn H Krystal
Jun 1, 2005·Neurobiology of Disease·Anna Maria LavezziLuigi Matturri
Dec 4, 2003·Biological Psychiatry·Carmen M Martin-RuizJennifer A Court
Apr 20, 2000·European Journal of Pharmacology·A KuryatovJ Lindstrom
Oct 16, 2002·Life Sciences·Mary B NewmanPaul R Sanberg
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·G Tanda, S R Goldberg
Dec 13, 2000·Pharmacology, Biochemistry, and Behavior·J E RoseM Johnson
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·M M FaradayN E Grunberg
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·Martha M FaradayNeil E Grunberg
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·J E RoseJ S Goldberg
Jan 28, 1999·Molecular and Cellular Endocrinology·L J Gooren
Apr 25, 2000·Molecular and Cellular Endocrinology·M Zitzmann, E Nieschlag
Sep 25, 2002·Neuroscience Letters·Helena GäddnäsLiisa Ahtee
Jan 1, 1997·Addictive Behaviors·J A SwansonL S Berk
Jan 29, 1999·Endocrinology and Metabolism Clinics of North America·J L Tenover
May 16, 2002·Neurotoxicology and Teratology·Theodore A Slotkin
Apr 1, 1992·Baillière's Clinical Endocrinology and Metabolism·F C Wu
May 20, 1999·Baillière's Clinical Endocrinology and Metabolism·A S Dobs
Dec 7, 2006·Nature Clinical Practice. Urology·Upendram Srinivas-Shankar, Frederick C W Wu
Apr 25, 2001·Clinical Endocrinology·B JinD J Handelsman
Jun 13, 2000·International Journal of Andrology·D J Handelsman
Mar 14, 1996·The New England Journal of Medicine·C J Bagatell, W J Bremner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.